The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

The Journal of Immunology, 2007, 179, 6134-6143
Copyright © 2007 by The American Association of Immunologists, Inc.
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lehnardt, S.
Right arrow Articles by Henneke, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lehnardt, S.
Right arrow Articles by Henneke, P.

TLR2 and Caspase-8 Are Essential for Group B Streptococcus-Induced Apoptosis in Microglia1

Seija Lehnardt2,*, Julia Wennekamp{dagger}, Dorette Freyer{ddagger}, Christian Liedtke§, Christina Krueger*, Robert Nitsch*, Ingo Bechmann, Joerg R. Weber*,{ddagger} and Philipp Henneke{dagger}

* Center for Anatomy, Institute of Cell Biology and Neurobiology, Charité-Universitaetsmedizin Berlin, Berlin, Germany; {dagger} Center for Pediatrics and Adolescent Medicine, Albert-Ludwigs-University, Freiburg, Germany; {ddagger} Department of Neurology, Charité-Universitaetsmedizin Berlin, Berlin, Germany; § Department of Medicine III, University Hospital Aachen, Aachen University, Aachen, Germany; and Institute of Clinical Neuroanatomy, J.W. Goethe-University, Frankfurt/Main, Germany


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Microglia, the resident innate immune cells of the CNS, detect invading pathogens via various receptors, including the TLR. Microglia are involved in a number of neurodegenerative diseases in which their activation may be detrimental to neurons. It is largely unknown how this potentially deleterious action can be countered on a cellular level. We previously found that the interaction of TLR2 with group B Streptococcus (GBS), the most important pathogen in neonatal bacterial meningitis, activates microglia that in turn generate neurotoxic NO. We report in this study that GBS not only activates microglia, but also induces apoptosis in these cells via TLR2 and the TLR-adaptor molecule MyD88. Soluble toxic mediators, such as NO, are not responsible for this form of cell death. Instead, interaction of GBS with TLR2 results in formation and activation of caspase-8, a process that involves the transcription factor family Ets. Whereas caspase-8 plays an essential role in GBS-induced microglial apoptosis, caspase-3 is dispensable in this context. We suggest that TLR2- and caspase-8-mediated microglial apoptosis constitutes an autoregulatory mechanism that limits GBS-induced overactivation of the innate immune system in the CNS.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Group B Streptococcus (GBS,3 or Streptococcus agalactiae) accounts for ~50% of all cases of neonatal meningitis (1) and represents the third most frequent cause of bacterial meningitis overall (2, 3). Bacterial meningitis is most commonly a manifestation of late-onset disease, which occurs after the first week of life and currently accounts for up to 50% of all neonatal cases of invasive GBS infections (4). GBS-induced meningitis is associated with long-term neurological and developmental morbidity, including cognitive impairment, language disorders, seizures, and motor handicaps, in up to 52% of surviving infants (5, 6). The molecular mechanisms underlying the damage to the immature brain are largely unresolved.

Microglia represent the resident immune host defense and are considered the major inflammatory cell type in the CNS. In CNS infection, microglia play an ambiguous role. On the one hand, microglia sense substructures of various pathogens and orchestrate the antimicrobial immune response that protects the brain against invading organisms. In contrast, activated microglia have been implicated in neurodegeneration resulting from bacterial meningitis, AIDS dementia complex, and multiple sclerosis, or associated with inflammation such as Parkinson’s disease or Alzheimer’s disease (7, 8, 9, 10). Upon activation, microglia secrete several proinflammatory and cytotoxic molecules, including ILs, TNF-{alpha}, reactive oxygen species such as NO, eicosanoids, and arachidonic acid metabolites (11). Accordingly, we have previously found that GBS potently induces secretion of NO in primary mouse microglia (12). An insufficient microglia-triggered inflammatory response that fails to prevent spread of pathogens such as GBS may have a potentially deleterious impact on neurons. In contrast, a sustained and therefore uncontrolled production of toxic products released from microglia may itself cause irreversible damage to neurons because neuronal tissue is not capable of self-regeneration. Thus, it is conceivable that via evolutionary forces the human brain has developed strategies to evade damage inflicted by its own local immune system. B and T lymphocytes undergo activation-induced cell death (AICD) that enables the organism to limit inflammatory processes (13, 14). Similar mechanisms have recently been described for macrophages and microglia (15, 16). Several pathogens including GBS induce apoptosis in macrophages to combat host immune defense (17, 18). In accordance with this, microglia and astrocytes undergo apoptosis upon inflammatory activation (19, 20). However, the molecular mechanisms that trigger and control bacteria-induced AICD in the CNS remain unclear.

We recently showed that GBS activates microglia via TLR2 and consequently leads to neuronal injury in vitro (12). TLRs recognize invariant molecular structures associated with pathogens and initiate an innate immune response (21). To date, 13 TLR orthologues, of which 10 are expressed in humans, have been identified. The best characterized pathway downstream of TLRs involves the intracellular proteins MyD88, IL-1R-associated kinases 1–4, and TNFR-associated factor 6. Activation of these molecules ultimately results in the activation of the transcriptional factor NF-{kappa}B (22). TLR2 recognizes several Gram-positive bacteria as well as the bacterial cell wall components peptidoglycan and lipoteichoic acid (LTA), and its activation results in the production of cytokines (23, 24). Although less well understood, it was recently reported that activation of TLRs not only leads to the expression of inflammatory response-related genes, but also triggers activation of proapoptotic signals. This feature has been linked to several TLRs, including TLR2 (25, 26) and TLR4 (27, 28).

In this study, we show that GBS induces apoptosis in microglia. In contrast to neuronal cell death triggered by GBS-activated microglia, apoptosis in microglia itself occurs independently of NO or other molecules secreted from microglia. GBS induces caspase-8, but not caspase-3, via TLR2. The Ets family of transcription factors is essential in this context. Accordingly, a functional TLR2 pathway is crucial not only for activation of microglia, but is also required for cell death and therefore silencing of microglia in response to the same organism.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 Disclosures
 References
 
Animals

MyD88–/– and TLR2–/– mice (29, 30) were provided by S. Akira, Department of Host Defense, Osaka University (Osaka, Japan). B6Smn.C3-Faslgld/J (Fas ligand (FasL)-deficient/gld) and C57BL/6J mice were purchased from The Jackson Laboratory. All animal experiments were conducted in accordance with the guidelines of the Charité animal facility and were approved by the local ethics committee.

Generation of heat-fixed (HF)-GBS and live GBS, HF-Streptococcus pneumoniae, and LTA

The GBS type III strains COH1 and NEM316, both of which were originally isolated from newborn infants with sepsis, the NEM316-derivative NEM1636, and S. pneumoniae (D39 capsular type 2) were cultured and heat fixed, as previously described (24, 31, 32). GBS NEM316 and 1636 were gifts of Patrick Trieucuot (Paris, France). Streptococcus aureus LTA was obtained from InvivoGen, and GBS LTA was prepared as previously described (24). Live GBS COH1 was maintained and grown in Todd-Hewitt broth (BD Diagnostics) as standing cultures at 37°C until the mid-log phase (~108 CFU/ml; OD600 = 0.4), at which point the bacteria were harvested, centrifuged, and resuspended in DMEM (Invitrogen Life Technologies) in indicated concentrations. HF-GBS was used throughout this study, unless otherwise indicated. In the case of HF-GBS, the concentrations are given as the number of bacteria equivalent to CFU, determined immediately before heat inactivation (as determined on blood agar).

Primary cultures of purified microglia

Purified microglia were generated from forebrains of P0-3 mice, as previously described (33). Briefly, brain tissue was dissociated with trypsin (Invitrogen Life Technologies) for 20 min at 37°C. After mechanical dissociation, cells were plated in 75-cm2 culture flasks in DMEM (Invitrogen Life Technologies) supplemented with 10% FBS and penicillin/streptomycin. After 10 days in culture, mixed glial cultures were shaken for 30 min at 180 rpm. The supernatant containing >97% microglia was plated on poly-D-lysine (BD Biosciences)-coated glass coverslips. Purified microglial cells were maintained in DMEM with 10% FBS at 37°C.

Cell staining

For isolectin B4 (IB4) staining, live cultures were incubated for 30 min with IB4 (Molecular Probes), washed with PBS, then fixed in fresh 4% paraformaldehyde in PBS for 10 min at ambient temperature and washed with PBS. For 4'6-diamino-2-phenylindole (DAPI) staining, cells were fixed with 4% paraformaldehyde and then incubated with DAPI (Molecular Probes) for 2 min. TUNEL staining of microglia was conducted using the In Situ Death Detection Kit, TMR red, according to the instruction manual (Roche). Caspase-8 staining was performed using the Image-iT LIVE Green Caspase-8 Detection kit, following the instruction manual (Molecular Probes). Finally, the cells were visualized by epifluorescence.

Measurement of nitrite

GBS-induced production of NO in microglia was analyzed by measuring the stable end product nitrite in the culture supernatants. The amount of NO2– was determined by using the colorimetric Griess reaction (Sigma-Aldrich), as described previously (34). The inducible NO synthase inhibitor aminoguanidine was also obtained from Sigma-Aldrich.

Western blotting

Cells were washed with PBS and lysed on ice in radioimmunoprecipitation assay buffer (50 mM Tris, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, and 1% sodium deoxycholate) with 10 mg/ml protease inhibitor mixture (Sigma-Aldrich). The protein extracts were boiled for 5 min, separated by SDS-PAGE, and transferred to nitrocellulose membrane. The membrane was blocked with 10% nonfat milk in PBS for 1 h at room temperature and incubated with an Ab directed against caspase-3 (1:100; Chemicon International) at 4°C overnight. Equal loading of protein was ensured by parallel probing with an Ab directed against beta-actin. Subsequently, the membrane was washed 3 x 5 min with 0.05% Tween 20 in PBS and then incubated with the appropriate secondary Ab (Amersham) for 1 h. After another round of washing, precipitates were visualized by ECL detection.

Reporter gene analysis

The human hepatoma cell line HuH7 was used in the reporter gene studies because it best supported the caspase-8 promoter. RT-PCR revealed weak, but reproducible transcription of TLR2. HuH7 cells were plated into 96-well tissue culture plates at a density of 5 x 103 cells/well. The following day, cells were transiently transfected with TransIT-LT1 Transfection Reagent (Mirus Bio) following the manufacturer’s protocol. The following luciferase reporter constructs were used: a bp-470/+76 construct of the caspase-8 promoter that has previously been shown to potently mediate transcriptional activation of the gene, and the –470/+76 caspase-8 construct containing a point mutation in an Ets-like element binding site ({Delta}ets) (35). In addition, cells were transfected with human TLR2-yellow fluorescent protein (36), as indicated. pcDNA was used to assure equal amounts of transfected DNA. The following day, cells were stimulated for 24 h, as indicated. Cells were then lysed in passive lysis buffer (Promega), and reporter gene activity was measured using a plate reader luminometer (MicroLumat Plus; Berthold Detection Systems).

Cytotoxicity experiments and statistical analysis

For experiments using HF-GBS, microglia were seeded at a density of 35,000 cells/well (96-well plates) or 120,000 cells/well (24-well plates). On the day of the experiment, the medium of the microglial cultures was completely replaced by 200 or 500 µl of fresh medium, respectively, and cultures were treated with 108 HF-GBS COH1/ml, unless noted otherwise. For experiments using live GBS, microglia were seeded at a density of 35,000 cells/well (96-well plates) and were incubated with 106 or 108 CFU live GBS/ml (106 CFU live GBS/ml are equivalent to a multiplicity of infection of 5). GBS LTA or S. aureus LTA were used in the indicated doses. For the caspase inhibition assays, 100 µM Z-VAD-FMK, 100 µM Z-IETD-FMK, or 120 µM DEVD-CHO (Calbiochem) was added 2 h before GBS treatment. Catalase (1250 U/ml) and FasL were purchased from Sigma-Aldrich. For experiments using Transwell chambers, Millicell cell culture insets (pore size 0.4 µm; Millipore) were used.

The figures show representative results from three to six independent experiments, each using triplicate wells. Data are expressed as mean ± SD. Statistical analysis was performed with SigmaStat version 2.03 (SPSS) using Student’s t test.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 Disclosures
 References
 
HF-GBS induces apoptosis in microglia

To investigate cytotoxic effects of GBS on microglia, microglia derived from cortices of wild-type mice were incubated with HF-GBS, and the effect was visualized by phase-contrast microscopy (Fig. 1A). In purified microglial cultures, HF-GBS induced a significant reduction of the cell number compared with control conditions. Next, we determined whether the cell death observed after incubation with HF-GBS was due to apoptosis. GBS-treated cell cultures were labeled with the isolectin IB4 to identify microglia, and then analyzed by TUNEL assay (Fig. 1B). Upon stimulation with HF-GBS, 95.1% of IB4-positive cells underwent apoptosis as indicated by TUNEL assay. Parallel immunostaining with the astrocyte-specific Ab glial fibrillary acidic protein demonstrated a purity of 97% for microglia in isolated glial cultures (data not shown). Staining with DAPI confirmed GBS-induced cell death by revealing morphological hallmarks of apoptosis, such as condensation, shrinkage, and fragmentation of the nuclei (Fig. 1C). DAPI staining did not only label the nuclei of microglia, but also stained, and therefore visualized, internalized HF-GBS in these cells.


Figure 1
View larger version (34K):
[in this window]
[in a new window]

  		FIGURE 1. HF-GBS induces apoptosis in microglia. Microglial cells were prepared from C57BL/6J mouse brains. Purified microglia were incubated with 108 HF-GBS/ml, whereas parallel control cultures were incubated with PBS. After 72 h, the cultures were examined by phase-contrast microscopy (A). Microglial cells incubated with 108 HF-GBS/ml were stained with IB4, fixed, and analyzed by TUNEL assay (B) or double stained with DAPI (C) after 36 h. Arrows indicate apoptotic cell bodies. Note the DAPI-labeled internalized bacteria in the cells (arrowheads). Scale bar, 50 µM. Microglia were incubated for 72 h with increasing concentrations of HF-GBS (D) or treated with 108 HF-GBS/ml for various incubation times (E). Cells were then stained for IB4 to mark microglia. IB4-positive cells were counted, and results were statistically expressed as relative microglial viability. The viability of control cells was set to 100%. Microglia were incubated at various doses (F) for various durations (G) with HF-S. pneumoniae, as indicated. Surviving IB4-positive cells were quantified, and results were expressed as relative microglial viability. All experiments were performed three to six times. Results are presented as mean ± SD. *, p < 0.001 (Student’s t test).

 
Dose-response experiments and subsequent quantitation of surviving IB4-positive cells showed a significant reduction in relative microglial viability after incubation with 107–109 HF-GBS/ml for 72 h (Fig. 1D). Incubation of microglia with 108 HF-GBS/ml for various incubation times led to a significant reduction in relative microglial viability after as soon as 48 h (Fig. 1E).

To test for the specificity of the used pathogen in terms of microglial toxicity, another Gram-positive bacteria, S. pneumoniae, which represents the primary cause of bacterial meningitis in children after the age of 3 mo, was analyzed for cytotoxic properties in microglial cultures. To this end, purified wild-type microglia were incubated at various doses (Fig. 1F) for various durations (Fig. 1G) with HF-S. pneumoniae, as indicated. Subsequent quantitation of surviving IB4-positive cells did not show a significant reduction of relative microglial viability after incubation with 105–109 HF-S. pneumoniae/ml during the whole round of observation. In contrast, incubation with 108 HF-GBS/ml led to a significant reduction of relative microglial viability after 72 h, as outlined above.

In summary, HF-GBS induces apoptosis in microglia in a dose- and time-dependent manner.

Microglial apoptosis induced by HF-GBS is not dependent on LTA

LTA is a conserved amphiphilic constituent of the cell wall in Gram-positive bacteria (37). It shares some features with the potent toxin LPS derived from Gram-negative bacteria, and has thus been proposed as being the functional equivalent in Gram-positive organisms (38). To assess the role of LTA in GBS-induced microglial apoptosis, microglia were purified from cortices of wild-type mice and subsequently incubated with various concentrations of GBS LTA for 72 h. Cells were then stained with IB4 and quantified (Fig. 2A). In contrast to the effect of whole GBS, GBS LTA did not significantly reduce microglial viability, even when used at very high concentrations. This finding was confirmed with LTA from S. aureus, which exceeds GBS LTA in inflammatory potency (24). S. aureus LTA did not induce cell death in microglia, even when used in concentrations 100-fold above those required to induce the release of cytokines (38). To extend these studies, microglial cells were incubated with HF-GBS COH1, NEM 316, or the NEM 316-derivate NEM 1636. The latter contains a disrupted alanine transferase (ltA) and has been shown to express alanine-free LTA (39). It has been suggested that LTA type I requires alanine substituents for proper inflammatory activation of phagocytes (38). After various times of incubation with wild-type HF-GBS (COH1 and NEM 316) or alanine transferase-deficient GBS (NEM 1636), microglia were fixed and analyzed by TUNEL assay (Fig. 2B). In accordance with the data on purified LTA that did not induce microglial cell death, modification of the LTA structure did not affect the apoptotic properties of whole GBS. Therefore, LTA is neither required nor sufficient for the induction of cell death in microglia.


Figure 2
View larger version (30K):
[in this window]
[in a new window]

  		FIGURE 2. LTA does not induce cell death in microglia. Microglia derived from C57BL/6J mice were incubated for 72 h with various concentrations of LTA derived from GBS or S. aureus. Subsequently, cells were stained with IB4, fixed, and quantified. Cell numbers were statistically expressed as relative microglial viability (A). Microglia were treated with HF-GBS COH1, HF-GBS NEM316, or HF-GBS NEM1636 in a dose of 108 HF-GBS/ml for various incubation times. Cells were then analyzed by TUNEL assay (B). Microglia were incubated with increasing concentrations of LTA derived from GBS (C) or S. aureus (D) for 12 h. Culture supernatants were then analyzed for TNF-{alpha} by ELISA. All experiments were performed three to six times. Results are presented as mean ± SD. *, p < 0.001 (Student’s t test).

 
To test whether LTA is capable of activating microglia, cells were analyzed for TNF-{alpha} secretion in response to LTA. Purified microglia derived from C57BL/6J mice were incubated for 12 h with increasing concentrations of LTA derived from GBS (Fig. 2C) or S. aureus (Fig. 2D). Microglia responded to both GBS LTA and S. aureus LTA with rapid secretion of TNF-{alpha} in a dose-dependent fashion. Thus, LTA activates microglia, but does not induce cell death in these cells.

In summary, HF-GBS-induced apoptosis in microglia is not dependent on LTA.

FasL is not involved in HF-GBS-induced microglial apoptosis

Next, we investigated the mechanisms by which GBS leads to microglial cell death. FasL is a type II transmembrane glycoprotein that binds to Fas, a transmembrane protein belonging to the TNFR family. After binding to FasL, Fas activates an intracellular signaling pathway that leads to apoptosis of the target cell (40). Fas/FasL plays a crucial role in the regulation of apoptosis of AICD in lymphocytes (41). Microglial cells express both Fas and FasL (42, 43) and are highly susceptible to apoptosis mediated by FasL (44, 45).

To assess the role of FasL in GBS-induced microglial cell death, microglia were prepared from forebrains of both B6Smn.C3-Faslgld/J (gld) mice lacking FasL and C57BL/6J wild-type mice. Cultures of microglia were incubated with various doses of HF-GBS for 72 h (Fig. 3A) or with 108 HF-GBS/ml for various incubation times (Fig. 3B), as indicated. Subsequently, IB4-positive cells were quantified. HF-GBS induced a significant reduction of IB4-positive cells in both wild-type cultures and cultures derived from gld mice, in a dose- and time-dependent fashion. Despite the fine titration of HF-GBS, we did not observe a significant difference between wild-type and gld microglia with respect to viability after incubation with HF-GBS. As a positive control for FasL-induced cell death, purified microglia derived from C57BL/6J mice were incubated with increasing concentrations of FasL for 72 h (Fig. 3C). Subsequently, IB4-positive cells were counted, and results were statistically expressed as relative microglial viability. Dose-response experiments revealed a significant reduction in relative microglial viability after incubation with 0.1 ng/ml FasL.


Figure 3
View larger version (17K):
[in this window]
[in a new window]

  		FIGURE 3. FasL is not involved in HF-GBS-induced apoptosis in microglia. Purified microglial cells derived from gld and C57BL/6J mice were incubated for 72 h with increasing concentrations of HF-GBS (A) or treated with 108 HF-GBS/ml for various incubation times (B). As a positive control for FasL-induced cell death, microglia derived from C57BL/6J mice were incubated with increasing concentrations of FasL for 72 h (C). Cells were then stained for IB4 to mark microglia. IB4-positive cells were counted, and results were statistically expressed as relative microglial viability. The viability of control cells was set to 100%. Experiments were performed three times. Results are presented as mean ± SD. p < 0.001 (Student’s t test).

 
In summary, these results demonstrate that FasL is not fundamentally involved in HF-GBS-induced microglial cell death.

Microglial apoptosis induced by HF-GBS is not due to soluble factors, such as NO

NO is a key mediator of GBS- and pneumococcus-induced apoptosis in macrophages (46, 47) and plays a major role in GBS-induced neuronal injury via microglia. To determine the role of soluble molecules secreted by activated microglia in GBS-induced microglial apoptosis, microglial cells from wild-type mice were incubated either with 108 HF-GBS/ml or PBS (control) for 72 h. Supernatants were then filtered through a 0.2-µm filter to both remove bacteria and save soluble molecules. Subsequently, freshly prepared wild-type microglia were incubated with the harvested supernatants. Microglia incubated with 108 HF-GBS/ml served as a positive control. Cell cultures were then stained with IB4 and analyzed by TUNEL assay (Fig. 4A). Whereas whole HF-GBS induced TUNEL positivity in most IB4-positive cells after 36 h, no TUNEL staining was observed in cultures treated with supernatants from HF-GBS-stimulated microglia for 36 h (data not shown) and 72 h (Fig. 4A). Data for the positive controls are shown for the 36-h time point because only few microglia were still viable after 72 h. To ensure that these results were not due to extended incubation times or labile cell-toxic molecules, the above experiment was repeated with supernatants harvested after 12, 24, 36, and 48 h of HF-GBS treatment. In concordance with the results described above, no TUNEL-positive cells were found (data not shown).


Figure 4
View larger version (47K):
[in this window]
[in a new window]

  		FIGURE 4. HF-GBS-induced cell death is not dependent on toxic soluble factors. Microglial cells were prepared from C57BL/6J mice and incubated with either 108 HF-GBS/ml or PBS (control) for 72 h. The supernatants were collected, filtered through 0.2-µm mesh filters, and added to freshly prepared microglia. After 72 h, cells were stained with IB4, fixed, and analyzed by TUNEL assay. The positive control is shown after 36 h of incubation because most microglia had died by 72 h (A). Scale bar, 50 µm. B, Using Transwell systems, 108 HF-GBS/ml were added to the upper chamber containing microglia or no cells, for indicated times. The addition of 108 HF-GBS/ml to the lower chamber containing microglia on cover glasses served as a positive control. Cell cultures of the lower chamber were then stained with IB4 and analyzed by TUNEL assay. C, Microglial cells were incubated with PBS (control), 100 µM aminoguanidine (AG), 108 HF-GBS/ml, or AG and HF-GBS in combination. After 72 h, cells were stained with IB4 and quantified. Cell numbers were statistically expressed as relative microglial viability. D, Microglia were incubated with either 108 HF-GBS/ml alone or in combination with 100 µM AG for various incubation times, as indicated. The amount of nitrite in the culture supernatants was determined using the Griess reaction. All experiments were performed three times. Results are presented as mean ± SD. p < 0.001 (Student’s t test).

 
To confirm that soluble molecules are not responsible for GBS-induced microglial apoptosis, we conducted experiments using Transwell chambers. Microglia were placed in the lower chamber, and the upper chamber inserts contained microglia or no cells. Next, 108 HF-GBS/ml was added to the upper chamber for 12, 24, 36, 48, or 72 h. The addition of 108 HF-GBS/ml for 36 h to the lower chamber served as a positive control. Cell cultures of the lower chamber were then stained with IB4 and analyzed by TUNEL assay (Fig. 4B). Whereas HF-GBS induced distinct TUNEL positivity in cultures treated with HF-GBS in the lower chamber, as observed above, only sporadic TUNEL staining was observed in the lower chamber when cultures in the upper chamber were treated with HF-GBS for various times, as indicated. Under these circumstances, the percentage of TUNEL-positive cells in the lower chamber did not significantly differ from control cultures (time 0 h).

To examine whether NO contributes to GBS-induced microglial cell death, wild-type microglia were incubated with either the inducible NO synthase inhibitor aminoguanidine (200 µM) or vehicle (control). After 2 h, HF-GBS was added, and after further 72 h of incubation, IB4-positive cells were quantified (Fig. 4C). In accordance with the data presented above, HF-GBS induced a significant reduction of IB4-positive cells without a measurable effect of aminoguanidine on this process. Notably, aminoguanidine abrogated HF-GBS-induced formation of NO throughout the entire period of observation (Fig. 4D).

In summary, these results indicate that HF-GBS-induced apoptosis in microglia is not caused by secreted factors and in particular not by NO.

Microglial apoptosis induced by HF-GBS and live GBS is dependent on MyD88 and TLR2

To test whether GBS-induced toxicity in microglia requires functional MyD88 and TLR2, purified microglial cells from C57BL/6J, MyD88–/–, and TLR2–/– mice were treated with 108 HF-GBS/ml for 36 h, and apoptosis was assessed by TUNEL assay (Fig. 5A). Whereas we routinely observed positive TUNEL staining in ~95% of wild-type microglial cells, hardly any TUNEL positivity was detected in microglia derived from MyD88–/– and TLR2–/– mice (<2% of cells) (Fig. 5B). To confirm that TLR2 and MyD88 are crucial for GBS-induced toxicity, we determined relative microglial viability after treatment with HF-GBS for 72 h. In accordance with the data presented above, microglia derived from MyD88–/– and TLR2–/– mice were completely protected against HF-GBS-induced cell death (Fig. 5C).


Figure 5
View larger version (56K):
[in this window]
[in a new window]

  		FIGURE 5. GBS-induced microglial cell death requires MyD88 and TLR2. Microglial cells derived from C57BL/6J, MyD88–/–, or TLR2–/– mice were incubated with 108 HF-GBS/ml for 36 h. Cells were then stained with IB4, fixed, and analyzed by TUNEL assay (A). Scale bar, 50 µm. Quantitation of TUNEL-positive microglia in the presence or absence of 108 HF-GBS/ml (B). Microglial cells prepared from C57BL/6J, MyD88–/–, and TLR2–/– mice were incubated with 108 HF-GBS/ml for 72 h. Surviving IB4-positive cells were quantified, and results were statistically expressed as relative microglial viability (C). Similar results were obtained in three experiments. The results are presented as mean ± SD. p < 0.001 (Student’s t test).

 
The described experiments using HF bacteria were intended to reveal interactions between the GBS cell wall and microglia. It seemed necessary to determine whether the interaction of GBS with TLR2 had an impact on microglial viability in the context of an in vivo infection model in which live GBS replicates and actively secretes molecules. Thus, purified microglial cells derived from C57BL/6J or TLR2–/– mice were incubated with 106 (Fig. 6A) and 108 (Fig. 6B) CFU live GBS/ml for various times, as indicated. Subsequently, cells were quantified, and relative microglial viability was assessed, setting the viability of control cells to 100%. We observed a significant decrease in microglial viability as early as 1.5 h after addition of live GBS. In contrast, microglia derived from TLR2–/– mice did not show decreased viability throughout the entire observation. Notably, live GBS induced cell death in microglia at a much faster rate than HF-GBS. However, in both cases, cell death was largely dependent on TLR2. Thus, nonspecific toxicity by GBS growing in culture appears to be negligible in our model.


Figure 6
View larger version (25K):
[in this window]
[in a new window]

  		FIGURE 6. Live GBS induces microglial cell death, which requires TLR2. Purified microglia derived from C57BL/6J or TLR2–/– mice were incubated with 106 (A) or 108 (B) CFU live GBS/ml for various incubation times. The surviving cells were quantified, and results were statistically expressed as relative microglial viability. Similar results were obtained in two additional experiments. Results are presented as mean ± SD. p < 0.001 (Student’s t test).

 
However, soluble molecules such as H2O2 might account for the differences in cell-death kinetics between microglia stimulated with live or HF-GBS. Live GBS produces and releases H2O2, which has been shown to mediate apoptosis in microglia in response to S. pneumoniae (48, 49). To assess the role of H2O2 in GBS-induced microglial apoptosis, H2O2 formation by live GBS was inhibited by the addition of catalase 1.5 h before exposure to wild-type microglia. The time course (1.5–9 h) and dose dependence (106, 107, and 108 CFU live GBS/ml) of microglial viability did not reveal differences between catalase-treated or nontreated microglia (data not shown). Thus, H2O2 appears not to be involved in microglial apoptosis induced by GBS.

It is well established that glucose can protect the immature brain from neuronal damage under specific circumstances (50, 51). Furthermore, we observed that the content of glucose decreased rapidly in both medium from wild-type and TLR2-deficient microglia during incubation with live GBS (S. Lehnardt, unpublished data). To exclude the possibility that glucose consumption by proliferating GBS and ensuing low glucose concentration in the medium caused microglial cell death, we repeated the experiments described above with the distinction that culture medium was substituted with fresh glucose (constant concentration at 4.5 mg/ml) during the whole length of the experiment. Glucose substitution remained without effect on microglial viability (data not shown). Thus, the content of glucose in the medium does not play a major role in microglial cell death induced by live GBS in vitro.

In summary, microglial cell death induced by HF-GBS and live GBS requires a functional MyD88 and TLR2 pathway in microglia. No qualitative difference was observed between HF-GBS and live GBS regarding dependence on TLR2.

HF-GBS-induced microglial cell death requires activation of caspase-8 that is dependent on TLR2, but does not involve caspase-3

The caspase family of cysteine-directed proteases represents one of the key regulators of apoptosis. Caspase-3 is a terminal effector molecule that, once activated, commits cells to death. GBS-induced apoptosis involves the activation of caspase-3 in macrophages (52). In this study, we assessed the role of caspase-3 in GBS-induced microglial apoptosis. Accordingly, lysates from microglia incubated with HF-GBS were tested for caspase-3 activation by Western blot with an Ab directed against cleaved caspase-3 (Fig. 7A). No cleaved caspase-3 was detected in HF-GBS-treated microglia, whereas this fragment was detected in microglia treated for 12 h with staurosporine. To further analyze the role of caspase-3 in GBS-induced microglial apoptosis, wild-type microglia were incubated either with the caspase-3-specific inhibitor DEVD-CHO or the broad-spectrum caspase inhibitor Z-VAD-FMK 2 h before treatment with HF-GBS. After 36 h, cells were stained with IB4 and TUNEL assay and were quantified (Fig. 7B). Whereas general inhibition of caspases significantly reduced HF-GBS-induced TUNEL positivity in microglia, specific inhibition of caspase-3 did not reduce the number of TUNEL-positive cells after incubation with HF-GBS. Microglial cells incubated with DEVD-CHO or Z-VAD-FMK alone were TUNEL-positive to a similar extent as it was observed for cells under control conditions.


Figure 7
View larger version (54K):
[in this window]
[in a new window]

  		FIGURE 7. Activation of caspase-8 is critically involved in HF-GBS-induced microglial cell death and requires TLR2. Microglial cells derived from C57BL/6J mice were incubated with 108 HF-GBS/ml or PBS for indicated times. Staurosporine-treated microglia served as a positive control. Cell lysates were resolved by SDS-PAGE and immunoblotted with an Ab directed against cleaved caspase-3 (A). Microglia were treated with either DEVD-CHO or Z-VAD-FMK for 2 h before the incubation with 108 HF-GBS/ml for 36 h. Cells were then stained with IB4 and TUNEL assay and quantified. Experiments are presented as mean ± SD. p < 0.001 (Student’s t test); n.s., not statistically significant (B). Microglial cells derived from C57BL/6J or TLR2–/– mice were incubated with 108 HF-GBS/ml or PBS for 24 h. Cells were then live stained with Image-iT LIVE Green Caspase-8 dye (C). Scale bar, 50 µm. Wild-type microglia were treated with either Z-VAD-FMK or Z-IETD-FMK for 2 h before the incubation with 108 HF-GBS/ml for 36 h. Cells were then stained with IB4 and TUNEL assay and quantified. Experiments are presented as mean ± SD. p < 0.001 (Student’s t test) for the comparison of the indicated groups with control and GBS (D). Microglia were incubated with 108 HF-GBS/ml in the presence of Z-IETD-FMK for 24 h and subsequently analyzed by the Image-iT LIVE Green Caspase-8 Detection assay. Scale bar, 10 µm (E). All experiments were performed three times.

 
Thus, whereas activation of caspases in general appeared to be critical for HF-GBS-induced cell death in microglia, the activation of caspase-3 was dispensable in this context.

Initiator caspases, such as caspase-8, are upstream caspases in apoptotic pathways and are triggered by the engagement of death receptors (53). TLR2-mediated apoptosis in HEK293 cells is executed by Fas-associated death domain protein and caspase-8 (25). To investigate the role of caspase-8 in GBS-induced apoptosis, wild-type and TLR2–/–-derived microglia were incubated with 108 HF-GBS/ml for 24 h and subsequently analyzed by the Image-iT LIVE Green Caspase-8 Detection assay, which only detects activated caspase-8 (Fig. 7C). As depicted in Fig. 7C, caspase-8 was activated by HF-GBS in wild-type microglia, but not in TLR2–/– microglia.

Next, we sought to confirm the functional relevance of activated caspase-8 in GBS-induced microglial apoptosis by using the caspase-8-specific inhibitor Z-IETD-FMK (Fig. 7D). Whereas most of the microglia became TUNEL-positive after incubation with HF-GBS, preincubation with the caspase-8-specific inhibitor and the general caspase inhibitor led to a significant reduction of TUNEL-positive microglia. As a control, microglia were incubated with 108 HF-GBS/ml in the presence of Z-IETD-FMK for 24 h and subsequently analyzed by the Image-iT LIVE Green Caspase-8 Detection assay (Fig. 7E). Caspase-8 activation by HF-GBS was inhibited in the presence of Z-IETD-FMK.

Taken together, caspase-8 plays a crucial role in HF-GBS-induced cell death in microglia.

GBS-TLR2 interaction results in activation of caspase-8

Next, we complemented our loss-of-function study on the role of TLR2 and caspase-8 with a gain-of-function model. Human hepatoma cells (HuH7) were transfected with TLR2 and a reporter that encoded for the promoter element of caspase-8 (bp –470/+76). Transcriptional activation of caspase-8 was induced by HF-GBS in a dose-dependent fashion, and TLR2 was essential for this activation (Fig. 8A). In contrast to the effects observed with GBS, LTA did not induce the caspase-8 reporter (data not shown). Notably, HuH7 cells expressed a low amount of endogenous TLR2, as determined by RT-PCR (data not shown), which might account for background stimulation in these cells. However, heterologous expression of TLR2 consistently increased this response. Furthermore, transcriptional activation of caspase-8 by HF-GBS was dependent on the Ets family of transcription factors, because a –470/+76 caspase-8 reporter containing a point mutation in an Ets-like element binding site was not activated by GBS (Fig. 8B).


Figure 8
View larger version (24K):
[in this window]
[in a new window]

  		FIGURE 8. GBS-TLR2 interaction results in potent caspase-8 activation. HuH7 cells were transfected with human TLR2 or vector control plus a luciferase reporter construct, as indicated. After 24 h, cells were stimulated with HF-GBS or PMA/ionomycin, as indicated. After further 24 h, cells were lysed and reporter activity was determined by luminometry. A, Caspase-8 wt reporter activation was normalized for percentage of PMA (10 ng/ml)/ionomycin (1 µg/ml) control. B, Caspase-8 wt: –470/+76 caspase-8 luciferase. Caspase-8 ets: –470/+76 caspase-8 luciferase reporter with targeting mutation in ets-binding site. The ratio of luciferase activity in induced and resting (medium) cells expressing similar transgenes (fold induction) is depicted. In all cases, mean + SEM from triplicate wells is depicted. All results were confirmed at least twice with similar results. *, p < 0.05; **, p < 0.01 for intervention vs medium control (Student’s t test).

 
In summary, HF-GBS-induced activation of caspase-8 is dependent on a functional TLR2 and the Ets family of transcription factors.


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
Disclosures
 References
 
Little is known about the fate of activated microglia during bacterial infections. GBS induces cell death in several cell types, including endothelial cells, macrophages, and monocytes (18, 54, 55). Data on molecular mechanisms that underlie these events are conflicting, and receptors mediating apoptosis in response to GBS have not been identified.

In this study, we report on a receptor-based mechanism by which GBS induces cell death in microglia via TLR2 and MyD88. Whereas TLR2 is firmly established as a receptor triggering inflammation in response to substructures derived from Gram-positive bacteria, its role in initiating apoptosis is less well understood. Early data on this topic, generated mainly in the context of protein overexpression, suggested TLR2, MyD88, and caspase-8 as mediators of apoptosis in response to bacterial lipoproteins (56). However, activation of TLR2 was found not to induce apoptosis in microglia (57). Our current study identified several novel aspects of apoptosis in microglia in response to GBS. First, stimulation of TLR2 by whole bacterial organisms, but not stimulation of TLR2 by a purified ligand, is sufficient to drive apoptosis in microglia. Second, TLR2 is necessary for microglial apoptosis in response to both live GBS and HF-GBS. Third, whereas GBS triggers predominantly antiapoptotic events in human monocytes, resulting in enhanced survival of the cells (55), microglia undergo apoptosis under the same conditions. Thus, apoptosis is a specific response of microglia to GBS. Fourth, apoptosis in microglia is a direct consequence of TLR2-mediated activation of caspase-8 and does not involve feedback loops comprising soluble toxins as reported for microglia-induced neuronal apoptosis.

In this study, we attempted to define whether LTA was involved in the interaction between microglia and GBS. LTA was an attractive candidate in this context because it is a GBS-derived ligand of TLR2 and a well-established TLR2 ligand of Gram-positive bacteria in general (24). However, several lines of evidence strongly suggest that LTA is of minor, if any, significance in GBS-induced cell death of microglia. First, although we found purified LTA to be capable of cell activation, we were unable to induce apoptosis in microglia with the same preparation, even when used in excessive concentrations (58). Second, a mutant GBS type that expressed dealanylated LTA induced apoptosis in microglia to a similar extent as in the isogenic parental strain. This finding has important implications. GBS must contain a pathogen-associated molecular pattern other than LTA that induces apoptosis via the engagement of TLR2. Moreover, stimulation of TLR2 alone is not sufficient to drive programmed cell death in microglia. This observation corresponds to a recent study by Jung et al. (57), who failed to induce microglial apoptosis with purified TLR2 agonists. It is tempting to speculate that GBS comprises a second, TLR2-independent molecule that synergizes with the TLR2 agonist for the induction of apoptosis.

Downstream of TLR2, we identified MyD88 and caspase-8 as crucial factors for GBS-induced apoptosis in microglia. Caspase-8 underlies significant posttranslational modification. The coupling to Fas-associated death domain protein results in the proteolytic cleavage of procaspase-8 into p18 und p10. These subunits are then released to the cytosol and mediate caspase activity via a C-terminal protease domain (59). In addition to posttranslational modifications, transcriptional regulation of caspase-8 appears to be essential for apoptosis, because heterologous expression of caspase-8 is sufficient to induce cell death (60). Expression of caspase-8 is reduced in a number of tumors such as neuroblastomas and neuroectodermal brain tumors due to somatic mutations and hypermethylation of genomic caspase-8 sequences (61, 62). Accordingly, we assessed in a gain-of-function approach whether GBS induces transcription of caspase-8 in vitro. We found that GBS induces caspase-8, and TLR2 and the Ets family of transcription factors are critical in this context. MAPKs can be assumed to be involved in caspase-8 activation because they have previously been shown to be essential for the activation of the Ets family of transcription factors that comprises ternary complex factors, such as Elk1 and Sap1a/b (63).

Besides TLRs, other molecules expressed by the host cell, such as FasL, have been implicated in apoptosis. It is well established that Fas/FasL play a crucial role in the regulation of apoptosis of AICD in lymphocytes (41). Microglia are particularly susceptible to FasL-induced apoptosis (44, 45). Using FasL-deficient mice, we showed that GBS-induced cell death is not dependent on the expression of FasL. This result is in accordance with a previous finding that a neutralizing Ab against FasL does not prevent LPS-induced apoptosis in the microglial cell line BV-2 (19). Mechanisms leading to AICD independently of Fas-FasL interaction are known: AICD in thymocytes does not involve FasL, but rather requires TRAIL or the activation of Bim, a member of the Bcl-2 family (64, 65). It remains to be elucidated whether molecules such as TRAIL are also involved in GBS-induced apoptosis of microglia in a manner similar to their role in GBS-induced apoptosis in monocytes (55).

Previous studies have identified microglial NO as a key mediator of GBS-induced neuronal injury and LPS-induced microglial apoptosis (12, 66). In contrast, we report in this study that NO or other secreted soluble molecules are not required for GBS-induced apoptosis in microglia.

Against the background of the data discussed above, the question arises how GBS-induced microglial cell death relates to the observation that gliosis follows various forms of CNS injury in vivo. Gliosis comprises several cell types, including reactive astrocytes, microglia, and oligodendrocytes. The relative contribution of the different glial subpopulations to gliosis varies greatly depending on the disease condition (67). Because the data presented in this study on microglia were raised in vitro, our model does not necessarily reflect all aspects leading to gliosis under the complex inflammatory conditions found in vivo. However, our finding that the interaction between GBS and TLR2 results in microglial cell death may suggest that the CNS has evolved mechanisms to limit the induction of gliosis in the context of GBS-induced infections. Ultimately, the role of GBS-induced microglial cell death needs to be further elucidated in in vivo models.

It has been a long-standing dispute whether bacteria-induced apoptosis of phagocytes is advantageous or harmful for the host. On the one hand, this process leads to the clearance of internalized bacteria, and therefore limits inflammation. In contrast, apoptosis of phagocytes is detrimental to the host because it may weaken the first-line immune defense (68). We speculate that apoptosis of phagocytes is per se neither good nor bad, but can be advantageous or disadvantageous for the fate of the host depending on infection-specific conditions, such as the causative bacterial species or the bacterial load. In line with this, both TNF-{alpha} and the TNF-inducing signaling intermediate MyD88 lower lethality in a low-dose (LD10) model of neonatal GBS sepsis in mice, but increase lethality upon inoculation of a high dose (LD90) in the same model (69). In the context of GBS meningitis, the physiological role of microglial apoptosis might depend on the stage of disease. In early stages of the infection, GBS-induced apoptosis of microglia may weaken the first line of defense in the CNS and therefore promote bacterial spread. However, once the infection is established, apoptosis of microglia may limit the formation of neurotoxic molecules, such as NO, and may therefore control the self-destructive nature of inflammation. Neuronal injury associated with bacterial meningitis results predominantly from the local inflammatory response by the host rather than from direct bacterial toxicity (70). Considering the poor capacity for neuronal regeneration, a mechanism evolved by the host organism to control an activated innate immune system seems essential (71). In line with this, AICD is considered a regulatory mechanism in lymphocytes, and more recently, in astrocytes and microglia (20, 66). On the basis of our data, TLRs may play a dual role in the microglial response in GBS meningitis. Within the framework of a mechanistic model, GBS triggers cell death in microglia via a signaling cascade, which shares molecules with the pathway that instructs the GBS-induced inflammatory host response in the CNS. Accordingly, TLR2 and MyD88 may be regarded as elaborate switches that mediate the self-control of CNS inflammation. Thus, it remains an important goal to decipher whether inefficient AICD in newborn infants contributes to neuronal damage in GBS meningitis to develop new therapeutic strategies.


   Acknowledgments
 
B6Smn.C3-Faslgld/J mice were provided by Dr. Ursula Felderhoff-Mueser, Department of Neonatology, Charité-Universitaetsmedizin Berlin. We thank A. Liebkowsky and E. Schott for critically reading this manuscript.


   Disclosures
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
References
 
The authors have no financial conflict of interest.


   Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported in part by a Rahel-Hirsch Grant from Charité-Universitaetsmedizin Berlin (to S.L.), by the National Institutes of Health, and by Deutsche Forschungsgemeinschaft (to P.H.). Back

2 Address correspondence and reprint requests to Dr. Seija Lehnardt, Center for Anatomy, Institute of Cell Biology and Neurobiology, Charité-Universitaetsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. E-mail address: seija.lehnardt{at}charite.de Back

3 Abbreviations used in this paper: GBS, group B Streptococcus; AICD, activation-induced cell death; DAPI, 4',6-diamidino-2-phenylindole; FasL, Fas ligand; HF, heat fixed; IB4, isolectin B4; LTA, lipoteichoic acid. Back

Received for publication December 13, 2006. Accepted for publication August 15, 2007.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 

  1. Volpe, J. J.. 2001. Neurology of the Newborn W. B. Saunders, Philadelphia.
  2. Domingo, P., N. Barquet, M. Alvarez, P. Coll, J. Nava, J. Garau. 1997. Group B streptococcal meningitis in adults: report of twelve cases and review. Clin. Infect. Dis. 25: 1180-1187. [Medline]
  3. Schuchat, A.. 1999. Group B streptococcus. Lancet 353: 51-56. [Medline]
  4. Fluegge, K., S. Supper, A. Siedler, R. Berner. 2005. Serotype distribution of invasive group B streptococcal isolates in infants: results from a nationwide active laboratory surveillance study over 2 years in Germany. Clin. Infect. Dis. 40: 760-763. [Medline]
  5. De Gans, J., D. van de Beek. 2002. Dexamethasone in adults with bacterial meningitis. N. Engl. J. Med. 347: 1549-1556. [Abstract/Free Full Text]
  6. Heath, P. T., G. Balfour, A. M. Weisner, A. Efstratiou, T. L. Lamagni, H. Tighe, L. A. O’Connell, M. Cafferkey, N. Q. Verlander, A. Nicoll, A. C. McCartney. 2004. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 363: 292-294. [Medline]
  7. Scheld, W. M., U. Koedel, B. Nathan, H. W. Pfister. 2002. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J. Infect. Dis. 186: (Suppl. 2):S225-S233. [Medline]
  8. Nau, R., W. Bruck. 2002. Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci. 25: 38-45. [Medline]
  9. Moore, S., S. Thanos. 1996. The concept of microglia in relation to central nervous system disease and regeneration. Prog. Neurobiol. 48: 441-460. [Medline]
  10. Kingham, P. J., M. L. Cuzner, J. M. Pocock. 1999. Apoptotic pathways mobilized in microglia and neurones as a consequence of chromogranin A-induced microglial activation. J. Neurochem. 73: 538-547. [Medline]
  11. Banati, R. B., J. Gehrmann, P. Schubert, G. W. Kreutzberg. 1993. Cytotoxicity of microglia. Glia 7: 111-118. [Medline]
  12. Lehnardt, S., P. Henneke, E. Lien, D. L. Kasper, J. J. Volpe, I. Bechmann, R. Nitsch, J. R. Weber, D. T. Golenbock, T. Vartanian. 2006. A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia. J. Immunol. 177: 583-592. [Abstract/Free Full Text]
  13. Donjerkovic, D., D. W. Scott. 2000. Activation-induced cell death in B lymphocytes. Cell Res. 10: 179-192. [Medline]
  14. Crispe, I. N.. 1999. Death and destruction of activated T lymphocytes. Immunol. Res. 19: 143-157. [Medline]
  15. Adler, B., H. Adler, T. W. Jungi, E. Peterhans. 1995. Interferon-{alpha} primes macrophages for lipopolysaccharide-induced apoptosis. Biochem. Biophys. Res. Commun. 215: 921-927. [Medline]
  16. Liu, B., K. Wang, H. M. Gao, B. Mandavilli, J. Y. Wang, J. S. Hong. 2001. Molecular consequences of activated microglia in the brain: overactivation induces apoptosis. J. Neurochem. 77: 182-189. [Medline]
  17. Zychlinsky, A., M. C. Prevost, P. J. Sansonetti. 1992. Shigella flexneri induces apoptosis in infected macrophages. Nature 358: 167-169. [Medline]
  18. Fettucciari, K., E. Rosati, L. Scaringi, P. Cornacchione, G. Migliorati, R. Sabatini, I. Fetriconi, R. Rossi, P. Marconi. 2000. Group B streptococcus induces apoptosis in macrophages. J. Immunol. 165: 3923-3933. [Abstract/Free Full Text]
  19. Lee, J., J. Hur, P. Lee, J. Y. Kim, N. Cho, S. Y. Kim, H. Kim, M. S. Lee, K. Suk. 2001. Dual role of inflammatory stimuli in activation-induced cell death of mouse microglial cells: initiation of two separate apoptotic pathways via induction of interferon regulatory factor-1 and caspase-11. J. Biol. Chem. 276: 32956-32965. [Abstract/Free Full Text]
  20. Suk, K., J. Lee, J. Hur, Y. S. Kim, M. Lee, S. Cha, S. Yeou Kim, H. Kim. 2001. Activation-induced cell death of rat astrocytes. Brain Res. 900: 342-347. [Medline]
  21. Armant, M. A., M. J. Fenton. 2002. Toll-like receptors: a family of pattern-recognition receptors in mammals. Genome Biol. 3: REVIEWS3011[Medline]
  22. Takeda, K., S. Akira. 2003. Toll receptors and pathogen resistance. Cell. Microbiol. 5: 143-153. [Medline]
  23. Akira, S., S. Uematsu, O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801. [Medline]
  24. Henneke, P., S. Morath, S. Uematsu, S. Weichert, M. Pfitzenmaier, O. Takeuchi, A. Muller, C. Poyart, S. Akira, R. Berner, et al 2005. Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J. Immunol. 174: 6449-6455. [Abstract/Free Full Text]
  25. Aliprantis, A. O., R. B. Yang, M. R. Mark, S. Suggett, B. Devaux, J. D. Radolf, G. R. Klimpel, P. Godowski, A. Zychlinsky. 1999. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285: 736-739. [Abstract/Free Full Text]
  26. Ruckdeschel, K., G. Pfaffinger, R. Haase, A. Sing, H. Weighardt, G. Hacker, B. Holzmann, J. Heesemann. 2004. Signaling of apoptosis through TLRs critically involves Toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages. J. Immunol. 173: 3320-3328. [Abstract/Free Full Text]
  27. Haase, R., C. J. Kirschning, A. Sing, P. Schrottner, K. Fukase, S. Kusumoto, H. Wagner, J. Heesemann, K. Ruckdeschel. 2003. A dominant role of Toll-like receptor 4 in the signaling of apoptosis in bacteria-faced macrophages. J. Immunol. 171: 4294-4303. [Abstract/Free Full Text]
  28. Zhang, Y., J. B. Bliska. 2003. Role of Toll-like receptor signaling in the apoptotic response of macrophages to Yersinia infection. Infect. Immun. 71: 1513-1519. [Abstract/Free Full Text]
  29. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143-150. [Medline]
  30. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11: 443-451. [Medline]
  31. Henneke, P., O. Takeuchi, J. A. van Strijp, H. K. Guttormsen, J. A. Smith, A. B. Schromm, T. A. Espevik, S. Akira, V. Nizet, D. L. Kasper, D. T. Golenbock. 2001. Novel engagement of CD14 and multiple Toll-like receptors by group B streptococci. J. Immunol. 167: 7069-7076. [Abstract/Free Full Text]
  32. Bermpohl, D., A. Halle, D. Freyer, E. Dagand, J. S. Braun, I. Bechmann, N. W. Schroder, J. R. Weber. 2005. Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways. J. Clin. Invest. 115: 1607-1615. [Medline]
  33. Vartanian, T., Y. Li, M. Zhao, K. Stefansson. 1995. Interferon-{gamma}-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol. Med. 1: 732-743. [Medline]
  34. Chen, W., U. Syldath, K. Bellmann, V. Burkart, H. Kolb. 1999. Human 60-kDa heat-shock protein: a danger signal to the innate immune system. J. Immunol. 162: 3212-3219. [Abstract/Free Full Text]
  35. Liedtke, C., N. Groger, M. P. Manns, C. Trautwein. 2003. The human caspase-8 promoter sustains basal activity through SP1 and ETS-like transcription factors and can be up-regulated by a p53-dependent mechanism. J. Biol. Chem. 278: 27593-27604. [Abstract/Free Full Text]
  36. Latz, E., A. Visintin, E. Lien, K. A. Fitzgerald, B. G. Monks, E. A. Kurt-Jones, D. T. Golenbock, T. Espevik. 2002. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the Toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J. Biol. Chem. 277: 47834-47843. [Abstract/Free Full Text]
  37. Neuhaus, F. C., J. Baddiley. 2003. A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in Gram-positive bacteria. Microbiol. Mol. Biol. Rev. 67: 686-723. [Abstract/Free Full Text]
  38. Morath, S., A. Stadelmaier, A. Geyer, R. R. Schmidt, T. Hartung. 2002. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J. Exp. Med. 195: 1635-1640. [Abstract/Free Full Text]
  39. Poyart, C., M. C. Lamy, C. Boumaila, F. Fiedler, P. Trieu-Cuot. 2001. Regulation of D-alanyl-lipoteichoic acid biosynthesis in Streptococcus agalactiae involves a novel two-component regulatory system. J. Bacteriol. 183: 6324-6334. [Abstract/Free Full Text]
  40. Nagata, S.. 1997. Apoptosis by death factor. Cell 88: 355-365. [Medline]
  41. Krueger, A., S. C. Fas, S. Baumann, P. H. Krammer. 2003. The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol. Rev. 193: 58-69. [Medline]
  42. Vogt, M., M. K. Bauer, D. Ferrari, K. Schulze-Osthoff. 1998. Oxidative stress and hypoxia/reoxygenation trigger CD95 (APO-1/Fas) ligand expression in microglial cells. FEBS Lett. 429: 67-72. [Medline]
  43. Dowling, P., G. Shang, S. Raval, J. Menonna, S. Cook, W. Husar. 1996. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184: 1513-1518. [Abstract/Free Full Text]
  44. Spanaus, K. S., R. Schlapbach, A. Fontana. 1998. TNF-{alpha} and IFN-{gamma} render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xL. Eur. J. Immunol. 28: 4398-4408. [Medline]
  45. Lee, J. M., M. C. Grabb, G. J. Zipfel, D. W. Choi. 2000. Brain tissue responses to ischemia. J. Clin. Invest. 106: 723-731. [Medline]
  46. Ulett, G. C., E. E. Adderson. 2005. Nitric oxide is a key determinant of group B streptococcus-induced murine macrophage apoptosis. J. Infect. Dis. 191: 1761-1770. [Medline]
  47. Marriott, H. M., F. Ali, R. C. Read, T. J. Mitchell, M. K. Whyte, D. H. Dockrell. 2004. Nitric oxide levels regulate macrophage commitment to apoptosis or necrosis during pneumococcal infection. FASEB J. 18: 1126-1128. [Abstract/Free Full Text]
  48. Wilson, C. B., W. M. Weaver. 1985. Comparative susceptibility of group B streptococci and Staphylococcus aureus to killing by oxygen metabolites. J. Infect. Dis. 152: 323-329. [Medline]
  49. Braun, J. S., J. E. Sublett, D. Freyer, T. J. Mitchell, J. L. Cleveland, E. I. Tuomanen, J. R. Weber. 2002. Pneumococcal pneumolysin and H2O2 mediate brain cell apoptosis during meningitis. J. Clin. Invest. 109: 19-27. [Medline]
  50. Vannucci, S. J., H. Hagberg. 2004. Hypoxia-ischemia in the immature brain. J. Exp. Biol. 207: 3149-3154. [Abstract/Free Full Text]
  51. Eklind, S., P. Arvidsson, H. Hagberg, C. Mallard. 2004. The role of glucose in brain injury following the combination of lipopolysaccharide or lipoteichoic acid and hypoxia-ischemia in neonatal rats. Dev. Neurosci. 26: 61-67. [Medline]
  52. Ulett, G. C., K. H. Maclean, S. Nekkalapu, J. L. Cleveland, E. E. Adderson. 2005. Mechanisms of group B streptococcal-induced apoptosis of murine macrophages. J. Immunol. 175: 2555-2562. [Abstract/Free Full Text]
  53. Lavrik, I. N., A. Golks, P. H. Krammer. 2005. Caspases: pharmacological manipulation of cell death. J. Clin. Invest. 115: 2665-2672. [Medline]
  54. Nizet, V., K. S. Kim, M. Stins, M. Jonas, E. Y. Chi, D. Nguyen, C. E. Rubens. 1997. Invasion of brain microvascular endothelial cells by group B streptococci. Infect. Immun. 65: 5074-5081. [Abstract]
  55. Halaas, O., N. B. Liabakk, R. Vik, C. Beninati, P. Henneke, A. Sundan, T. Espevik. 2004. Monocytes stimulated with group B streptococci or interferons release tumor necrosis factor-related apoptosis-inducing ligand. Scand. J. Immunol. 60: 74-81. [Medline]
  56. Aliprantis, A. O., R. B. Yang, D. S. Weiss, P. Godowski, A. Zychlinsky. 2000. The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J. 19: 3325-3336. [Medline]
  57. Jung, D. Y., H. Lee, B. Y. Jung, J. Ock, M. S. Lee, W. H. Lee, K. Suk. 2005. TLR4, but not TLR2, signals autoregulatory apoptosis of cultured microglia: a critical role of IFN-beta as a decision maker. J. Immunol. 174: 6467-6476. [Abstract/Free Full Text]
  58. Kinsner, A., M. Boveri, L. Hareng, G. C. Brown, S. Coecke, T. Hartung, A. Bal-Price. 2006. Highly purified lipoteichoic acid induced pro-inflammatory signalling in primary culture of rat microglia through Toll-like receptor 2: selective potentiation of nitric oxide production by muramyl dipeptide. J. Neurochem. 99: 596-607. [Medline]
  59. Strasser, A., L. O’Connor, V. M. Dixit. 2000. Apoptosis signaling. Annu. Rev. Biochem. 69: 217-245. [Medline]
  60. Muzio, M., A. M. Chinnaiyan, F. C. Kischkel, K. O’Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J. D. Bretz, M. Zhang, R. Gentz, et al 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817-827. [Medline]
  61. Teitz, T., T. Wei, M. B. Valentine, E. F. Vanin, J. Grenet, V. A. Valentine, F. G. Behm, A. T. Look, J. M. Lahti, V. J. Kidd. 2000. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat. Med. 6: 529-535. [Medline]
  62. Zuzak, T. J., D. F. Steinhoff, L. N. Sutton, P. C. Phillips, A. Eggert, M. A. Grotzer. 2002. Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumor/medulloblastoma. Eur. J. Cancer 38: 83-91. [Medline]
  63. Yordy, J. S., R. C. Muise-Helmericks. 2000. Signal transduction and the Ets family of transcription factors. Oncogene 19: 6503-6513. [Medline]
  64. Lamhamedi-Cherradi, S. E., S. J. Zheng, K. A. Maguschak, J. Peschon, Y. H. Chen. 2003. Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL–/– mice. Nat. Immunol. 4: 255-260. [Medline]
  65. Bouillet, P., J. F. Purton, D. I. Godfrey, L. C. Zhang, L. Coultas, H. Puthalakath, M. Pellegrini, S. Cory, J. M. Adams, A. Strasser. 2002. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415: 922-926. [Medline]
  66. Lee, P., J. Lee, S. Kim, M. S. Lee, H. Yagita, S. Y. Kim, H. Kim, K. Suk. 2001. NO as an autocrine mediator in the apoptosis of activated microglial cells: correlation between activation and apoptosis of microglial cells. Brain Res. 892: 380-385. [Medline]
  67. Croisier, E., M. B. Graeber. 2006. Glial degeneration and reactive gliosis in {alpha}-synucleinopathies: the emerging concept of primary gliodegeneration. Acta Neuropathol. 112: 517-530. [Medline]
  68. Hotchkiss, R. S., I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348: 138-150. [Free Full Text]
  69. Mancuso, G., A. Midiri, C. Beninati, C. Biondo, R. Galbo, S. Akira, P. Henneke, D. Golenbock, G. Teti. 2004. Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease. J. Immunol. 172: 6324-6329. [Abstract/Free Full Text]
  70. Spellerberg, B., E. I. Tuomanen. 1994. The pathophysiology of pneumococcal meningitis. Ann. Med. 26: 411-418. [Medline]
  71. Jones, L. L., R. B. Banati, M. B. Graeber, L. Bonfanti, G. Raivich, G. W. Kreutzberg. 1997. Population control of microglia: does apoptosis play a role?. J. Neurocytol. 26: 755-770. [Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lehnardt, S.
Right arrow Articles by Henneke, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lehnardt, S.
Right arrow Articles by Henneke, P.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS